Frank Rimerman Advisors’s Bio-Techne TECH Stock Holding History

Frank Rimerman Advisors’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-2,507	Closed	-$200K	–	561
2024 Q3	$200K	Buy	+2,507	New	+$188K	0.01%	518

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Frank Rimerman Advisors's TECH Position: Q4 2024 in Review

Frank Rimerman Advisors sold out of Bio-Techne (TECH) in Q4 2024, closing a stake of 2,507 shares — an estimated $200K sold.

Frank Rimerman Advisors first reported a position in TECH in Q3 2024 and held it in 1 quarter. The position peaked at $200K in Q3 2024. 576 funds tracked by Wall St. Rank hold TECH as of Q4 2024.

Frank Rimerman Advisors reported no remaining Bio-Techne position as of Q4 2024 after selling out during the quarter.
Frank Rimerman Advisors sold 2,507 Bio-Techne shares in Q4 2024, an estimated $200K.
Frank Rimerman Advisors first reported a position in Bio-Techne in Q3 2024 and held it in 1 quarter.
Frank Rimerman Advisors's Bio-Techne position peaked at $200K in Q3 2024.
576 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2024.

Based on Frank Rimerman Advisors's 13F filing for Q4 2024, filed 10 Feb 2025.